Magnetic Nanoparticles in Cancer Therapy and Diagnosis.
Ali FarzinSeyed Alireza EtesamiJacob QuintAdnan MemicAli TamayolPublished in: Advanced healthcare materials (2020)
There is urgency for the development of nanomaterials that can meet emerging biomedical needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface-area-to-volume ratios that make them attractive for hyperthermia therapy of cancer and targeted drug delivery. Additionally, they can function as contrast agents for magnetic resonance imaging (MRI) and can improve the sensitivity of biosensors and diagnostic tools. Recent advancements in nanotechnology have resulted in the realization of the next generation of MNPs suitable for these and other biomedical applications. This review discusses methods utilized for the fabrication and engineering of MNPs. Recent progress in the use of MNPs for hyperthermia therapy, controlling drug release, MRI, and biosensing is also critically reviewed. Finally, challenges in the field and potential opportunities for the use of MNPs toward improving their properties are discussed.
Keyphrases
- magnetic nanoparticles
- drug delivery
- cancer therapy
- drug release
- magnetic resonance imaging
- contrast enhanced
- diffusion weighted imaging
- computed tomography
- papillary thyroid
- mesenchymal stem cells
- high resolution
- young adults
- bone marrow
- climate change
- cell therapy
- label free
- mass spectrometry
- simultaneous determination